Nanocarriers In Modern Drug Delivery: Advances, Challenges, And Future Directions
Future Journal of Pharmaceuticals and Health Sciences · 02.05.2026 · 6 (2) · 114-129
DOI: 10.26452/fjphs.v6i2.568 ↗Kurz gefasst
Fachartikel in der Zeitschrift Future Journal of Pharmaceuticals and Health Sciences, online erschienen am 02.05.2026. Verfasst von {"name":"Babitha Angel Medikonda","email":"babithaangelm@vsu.ac.in","affiliat.
Abstract (Originalsprache)
Nanocarriers have emerged as a promising approach in modern drug delivery systems due to their ability to enhance drug bioavailability, stability, and targeted delivery. These nanoscale carriers (1 – 1000 nm) protect therapeutic agents from degradation and i mprove pharmacokinetic and pharmacodynamic profiles. Despite their advantages, conventional nanocarriers face limitations such as low accumulation at target sites and off - target toxicity. To address these challenges, advanced strategies including active an d passive targeting, as well as subcellular - level targeting, have been developed to improve therapeutic precision.Nanocarriers are broadly classified into organic (liposomes, dendrimers, polymeric micelles), inorganic (gold nanoparticles, carbon nanotubes, quantum dots), and hybrid systems, each offering unique properties for drug and gene delivery. Drug loading techniques such as encapsulation, covalent bonding, and electrostatic interactions enable controlled and sustained release of therapeutic agents. T hese systems play a significant role in applications such as cancer therapy, gene delivery, immunotherapy, and vaccine development.Recent advancements include stimuli - responsive nanoparticles, theranostic systems, and personalized nanomedicine, which integ rate diagnosis and treatment for improved clinical outcomes. Continued research focusing on safety, regulatory frameworks, and scalable production is essential to fully realize their clinical applications.
Zitieren
APA
Medikonda","email":"babithaangelm@vsu.ac.in","affiliat, N. A. (2026). Nanocarriers In Modern Drug Delivery: Advances, Challenges, And Future Directions. Future Journal of Pharmaceuticals and Health Sciences, 6(2), 114-129. https://doi.org/10.26452/fjphs.v6i2.568
Vancouver
Medikonda","email":"babithaangelm@vsu.ac.in","affiliat NA. Nanocarriers In Modern Drug Delivery: Advances, Challenges, And Future Directions. Future Journal of Pharmaceuticals and Health Sciences. 2026;6(2):114-129. doi:10.26452/fjphs.v6i2.568
BibTeX
@article{Medikondaemailbabithaangelmvsuacinaffiliat2026,
author = {Medikonda","email":"babithaangelm@vsu.ac.in","affiliat, "name":"Babitha Angel},
title = {Nanocarriers In Modern Drug Delivery: Advances, Challenges, And Future Directions},
journal = {Future Journal of Pharmaceuticals and Health Sciences},
year = {2026},
volume = {6},
number = {2},
pages = {114--129},
doi = {10.26452/fjphs.v6i2.568}
}
EUVIMED